M Briffod

805 total citations
29 papers, 603 citations indexed

About

M Briffod is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, M Briffod has authored 29 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in M Briffod's work include Cancer Cells and Metastasis (7 papers), Cancer Genomics and Diagnostics (7 papers) and Breast Cancer Treatment Studies (6 papers). M Briffod is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Cancer Genomics and Diagnostics (7 papers) and Breast Cancer Treatment Studies (6 papers). M Briffod collaborates with scholars based in France, United States and Spain. M Briffod's co-authors include Rosette Lidereau, Keltouma Driouch, Ivan Bièche, V Le Doussal, C. Pallud, M.H. Champème, M. Tubiana-Hulin, Jacques Rouëssé, K. Hacène and Antonio Gentile and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

M Briffod

27 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Briffod France 12 312 261 239 136 65 29 603
Emanuela Balladore Italy 8 405 1.3× 132 0.5× 272 1.1× 92 0.7× 67 1.0× 14 771
Kristen E. Muller United States 15 275 0.9× 162 0.6× 196 0.8× 88 0.6× 77 1.2× 42 587
Peter Čamaj Germany 16 355 1.1× 279 1.1× 507 2.1× 52 0.4× 78 1.2× 22 788
Michiko Harao Japan 16 329 1.1× 132 0.5× 362 1.5× 101 0.7× 88 1.4× 36 915
H.M. Ruitenberg Netherlands 8 188 0.6× 241 0.9× 127 0.5× 123 0.9× 53 0.8× 12 509
David Browell United Kingdom 13 277 0.9× 129 0.5× 286 1.2× 36 0.3× 84 1.3× 26 608
Tarek M. Abdel-Fatah United Kingdom 14 268 0.9× 341 1.3× 327 1.4× 159 1.2× 33 0.5× 21 643
Caroline O. Michie United Kingdom 10 216 0.7× 154 0.6× 207 0.9× 66 0.5× 50 0.8× 20 562
Benjamin Toh Singapore 7 493 1.6× 134 0.5× 203 0.8× 44 0.3× 65 1.0× 10 854
Iwao Yabuuchi Japan 9 252 0.8× 95 0.4× 276 1.2× 75 0.6× 53 0.8× 17 645

Countries citing papers authored by M Briffod

Since Specialization
Citations

This map shows the geographic impact of M Briffod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Briffod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Briffod more than expected).

Fields of papers citing papers by M Briffod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Briffod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Briffod. The network helps show where M Briffod may publish in the future.

Co-authorship network of co-authors of M Briffod

This figure shows the co-authorship network connecting the top 25 collaborators of M Briffod. A scholar is included among the top collaborators of M Briffod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Briffod. M Briffod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Becette, Véronique, Florence Lerebours, Frédérique Spyratos, et al.. (2011). Immunomarker Studies of Fine-Needle Cytopuncture Cell Blocks for Tumor Response Prediction After Preoperative Chemotherapy and Prognosis in Operable Nonmetastatic Primary Breast Carcinoma. The Breast Journal. 17(2). 121–128. 3 indexed citations
2.
Weiswald, Louis‐Bastien, Sophie Richon, Pierre Validire, et al.. (2009). Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness. British Journal of Cancer. 101(3). 473–482. 64 indexed citations
3.
Jackson, Amanda, Akeila Bellahcène, Nadia Rucci, et al.. (2008). A Six-Gene Signature Predicting Breast Cancer Lung Metastasis. Cancer Research. 68(15). 6092–6099. 121 indexed citations
4.
Menet, Emmanuelle, Véronique Becette, & M Briffod. (2008). Cytologic diagnosis of lobular carcinoma of the breast. Cancer. 114(2). 111–117. 11 indexed citations
5.
Denoux, Yves, et al.. (2003). [2002 Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens].. PubMed. 23(3). 266–78. 3 indexed citations
6.
Denoux, Yves, et al.. (2002). Standards, Options et Recommandations : bonne pratique de l'acheminement et de la prise en charge initiale d'un prélèvement en anatomie et cytologie pathologiques en cancérologie. Bulletin du Cancer. 89(4). 3 indexed citations
7.
Briffod, M, V Le Doussal, & F. Spyratos. (2001). [Immunohistochemical determination of hormonal receptors on cell-blocks from fine-needle cytopunctures of breast carcinoma].. PubMed. 88(10). 1028–35. 4 indexed citations
8.
Briffod, M, K. Hacène, & V Le Doussal. (2000). Immunohistochemistry on Cell Blocks From Fine-Needle Cytopunctures of Primary Breast Carcinomas and Lymph Node Metastases. Modern Pathology. 13(8). 841–850. 39 indexed citations
9.
Fiche, Maryse, M P Blanc-Vincent, V Le Doussal, et al.. (2000). [Standards, Options and Recommendations (SOR) for drafting of anatomic and surgical pathology reports or cytopathology reports in oncology].. PubMed. 87(2). 159–71. 8 indexed citations
10.
Wang, Qing, Keltouma Driouch, Stéphanie Courtois, et al.. (1998). Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers. Oncogene. 16(5). 677–679. 18 indexed citations
11.
Driouch, Keltouma, M Briffod, Ivan Bièche, M.H. Champème, & Rosette Lidereau. (1998). Location of several putative genes possibly involved in human breast cancer progression.. PubMed. 58(10). 2081–6. 36 indexed citations
12.
Briffod, M, V Le Doussal, & F. Spyratos. (1997). Cytologic nuclear grading of fine needle cytopunctures of breast carcinoma. Comparison with histologic nuclear grading and image cytometric data.. PubMed. 19(2). 114–22. 11 indexed citations
13.
Driouch, Keltouma, Françoise Dorion-Bonnet, M Briffod, et al.. (1997). Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chromosomes and Cancer. 19(3). 185–191. 61 indexed citations
14.
Briffod, M, Frédérique Spyratos, K. Hacène, et al.. (1992). Evaluation of breast carcinoma chemosensitivity by flow cytometric DNA analysis and computer assisted image analysis. Cytometry. 13(3). 250–258. 25 indexed citations
16.
Briffod, M, et al.. (1992). [Puncture of bone lesions under tomodensitometric control].. PubMed. 79(5). 483–90. 1 indexed citations
18.
Briffod, M, et al.. (1982). [Retroperitoneal malignant xanthogranuloma (author's transl)].. PubMed. 58(2). 113–9. 2 indexed citations
19.
Briffod, M, Antonio Gentile, & Hans Hebert. (1982). Cytopuncture in the follow-up of breast carcinoma.. PubMed. 26(2). 195–200. 36 indexed citations
20.
Doussal, V Le, et al.. (1980). [Deceptive form of anaplastic carcinoma of the breast simulating a lymphoma: cytologic, histologic and ultrastructural examination of two cases (author's transl)].. PubMed. 28(4). 238–44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026